Errata: Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM)

159 Aufrufe

DOI:

10.3791/5755

Nicht veröffentlicht

In diesem Artikel

Zusammenfassung

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM).

Zusammenfassung

Protokoll

An erratum was issued for Detection of Exosomal Biomarker by Electric Field-induced Release and Measurement (EFIRM). The disclosures were updated from:

David Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. PeriRx LLC sublicensed intellectual properties pertaining to molecular diagnostics from RNAmeTRIX. David Wong is a consultant to PeriRx.

to

David T. Wong is co-founder of RNAmeTRIX Inc., a molecular diagnostic company. He holds equity in RNAmeTRIX, and serves as a company director and scientific advisor. The University of California also holds equity in RNAmeTRIX. Intellectual property that David T. Wong invented and which was patented by the University of California has been licensed to RNAmeTRIX. Additionally, he is a paid consultant to PeriRx.

Offenlegungen

No conflicts of interest declared.

Nachdrucke und Genehmigungen

Tags

Biomarker-DetektionExosomenanalyseAnwendung eines elektrischen FeldesBiomarker-MessungExosomenfreisetzungDetektionsmethodeBiomarker-Analyse